ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 155 out of 1844

$694K Total Retail Price of All Prescriptions

Rank: 152 out of 1844

509 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 563 419 S3 1 2
SIMVASTATIN 414 387 2 3
LEVOTHYROXINE SODIUM 403 315 3 1
MELOXICAM 333 273 4 28
FUROSEMIDE 312 285 5 7
OMEPRAZOLE 259 207 6 5
LISINOPRIL 239 208 7 4
PANTOPRAZOLE SODIUM 233 205 8 32
ZOLPIDEM TARTRATE 214 179 9 23
ATENOLOL 197 158 10 17
AMLODIPINE BESYLATE 187 169 11 6
METOPROLOL TARTRATE 160 144 12 11
POTASSIUM CHLORIDE 158 113 13 16
CITALOPRAM HBR 157 130 14 19
CARBIDOPA-LEVODOPA 156 114 15 86
SPIRONOLACTONE 152 128 16 60
ESCITALOPRAM OXALATE 143 66 17 52
ISOSORBIDE MONONITRATE ER 139 139 18 59
GABAPENTIN 138 99 19 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 133 20 20
KLOR-CON M20 137 124 20 54
NEXIUM 134 116 22 31
ATORVASTATIN CALCIUM 122 81 23 12
HYDROCHLOROTHIAZIDE 120 94 24 9
CYMBALTA 117 93 25 36
TRIAMTERENE-HYDROCHLOROTHIAZID 117 91 25 161
DONEPEZIL HCL 99 99 27 26
DILTIAZEM ER 95 94 28 200
SERTRALINE HCL 95 67 28 21
HYDRALAZINE HCL 94 92 30 120
CLOPIDOGREL 92 87 31 34
TRAMADOL HCL 90 29 32 18
WARFARIN SODIUM 90 90 32 13
LOSARTAN POTASSIUM 90 86 32 24
DIGOXIN 85 85 35 67
METFORMIN HCL 85 77 35 8
BUMETANIDE 84 72 37 121
LOSARTAN-HYDROCHLOROTHIAZIDE 80 71 38 47
TAMSULOSIN HCL 75 75 39 27
POLYETHYLENE GLYCOL 3350 74 41 40 39
GLIMEPIRIDE 73 72 41 35
SPIRIVA 71 69 42 57
AZITHROMYCIN 71 54 42 37
CRESTOR 68 37 44 30
ALLOPURINOL 67 65 45 29
DOXYCYCLINE HYCLATE 67 59 45 90
CELEBREX 67 50 45 91
DILTIAZEM 24HR ER 67 66 45 146
NAMENDA 64 64 49 33
TRAZODONE HCL 62 47 50 43
PLAVIX 59 55 51 61
OXYCODONE HCL-ACETAMINOPHEN 59 23 S2 51 83
SYNTHROID 58 54 53 55
VYTORIN 57 40 54 211
METOPROLOL SUCCINATE 56 56 55 14
CIPROFLOXACIN HCL 54 48 56 62
TRIAMTERENE-HCTZ 54 52 56 48
LYRICA 53 36 58 92
DILTIAZEM 24HR CD 51 46 59 132
PROAIR HFA 51 50 59 45
PREMARIN 51 38 R 59 171
PROMETHAZINE HCL 50 20 R 62 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.